Industry Research
-
Manufacturing Expenditure By Activity
9/1/2020
We asked sponsors who outsource clinical manufacturing to identify which activities they spend the most on.
-
Trends In Bioprocessing CDMO Selection
8/3/2020
Which CDMO characteristics do experienced outsourcers value the most when choosing a CDMO for biologic API production? Data from the past three iterations of ISR’s Bioprocessing Market Trends and Outsourcing Dynamics show the top selection metrics remain consistent despite some shifts in ranks over the years. Learn which attributes to focus on as a sponsor or CDMO.
-
Small & Emerging Outsourced Manufacturing Activities
8/3/2020
To better understand the outsourcing practices used by respondents’ companies, ISR asked research participants to provide an estimate for various manufacturing activities.
-
Attributes Gaining Importance In Clinical Research
7/1/2020
What sponsors need from their clinical research partners can shift year to year, which is why ISR asks our respondents about which attributes they believe to be rising in importance when choosing between preferred providers. Below, we share the top three attributes gaining in importance across all clinical phases.
-
Use Of Outside Consultants In Phase 2/3 Clinical Research
6/1/2020
In addition to the role that preferred provider agreements (PPAs) play in the process, companies also seek assistance from specialized outside consultants to help with their outsourcing decisions.
-
Technology In Clinical Trials: Differences By Company Size
5/1/2020
ISR Research took a look at where large vs. nonlarge sponsors differ in terms of openness to emerging trends in clinical development.
-
Sponsor Challenges When Outsourcing Sterile Injectables
4/1/2020
ISR asked outsourcers of sterile injectable drug product to identify their biggest challenge when outsourcing to CDMOs/CMOs. We were surprised to see a nearly four-way tie in the results. In this article, we’ll take a closer look at one of these challenges.
-
Use Of TMF Solutions In Clinical Development Studies
4/1/2020
Nearly two-thirds of clinical development studies are currently using a software vendor-designed eTMF application. A slight increase (71%) is expected three years from now.
-
Pharmacovigilance Technology And The Adoption Of AI
2/28/2020
We asked 100 decision-makers in the pharmacovigilance space where in the adoption curve of new technologies they see their organizations with respect to AI in pharmacovigilance.
-
Sole Sourcing Arrangements For Central Labs
1/31/2020
In a recent study, 4 percent of respondents reported using a sole sourcing model, whereby sponsors select a single central lab for all their testing needs.